Your browser doesn't support javascript.
loading
Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.
Perkins, Alan C; Blackshaw, P Elaine; Hay, Peter D; Lawes, Simon C; Atherton, Clare T; Dansereau, Richard J; Wagner, Leigh K; Schnell, Dan J; Spiller, Robin C.
Affiliation
  • Perkins AC; Academic Medical Physics and Wolfson Digestive Diseases Centre, University Hospital, Nottingham, United Kingdom. alan.perkins@nottingham.ac.uk
Clin Ther ; 30(5): 834-44, 2008 May.
Article in En | MEDLINE | ID: mdl-18555931
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Transit / Drugs, Generic / Etidronic Acid / Alendronate / Esophagus / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Ther Year: 2008 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Transit / Drugs, Generic / Etidronic Acid / Alendronate / Esophagus / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Ther Year: 2008 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos